COL6A1 and metastatic malignant neoplasm in the lymph nodes: In summary, a sensitive electrochemical biosensor was successfully developed to detect and quantify CSTB, LTA4H, and COL6A1 biomarkers in noninvasive saliva samples from OSCC patients, with and without lymph node metastasis.